Scotia Capital’s Calumet Specialty Products CLMT Stock Holding History

Scotia Capital’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,841	Closed	-$317K	–	924
2026 Q1	$317K	Buy	+8,841	New	+$229K	﹤0.01%	753

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Scotia Capital's CLMT Position: Q2 2026 in Review

Scotia Capital sold out of Calumet Specialty Products (CLMT) in Q2 2026, closing a stake of 8,841 shares — an estimated $317K sold.

Scotia Capital first reported a position in CLMT in Q1 2026 and held it in 1 quarter. The position peaked at $317K in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

Scotia Capital reported no remaining Calumet Specialty Products position as of Q2 2026 after selling out during the quarter.
Scotia Capital sold 8,841 Calumet Specialty Products shares in Q2 2026, an estimated $317K.
Scotia Capital first reported a position in Calumet Specialty Products in Q1 2026 and held it in 1 quarter.
Scotia Capital's Calumet Specialty Products position peaked at $317K in Q1 2026.
188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on Scotia Capital's 13F filing for Q2 2026, filed 11 Aug 2026.